Truist cuts Brown & Brown stock price target to $85 on lower estimates

Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.

Original reporting
Published Oct 27, 2026, 5:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 5:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BRO
Bearish
high confidence
Mentioned
$BRO
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BROBearishMed
01

Why it matters

The analyst downgrade and earnings miss are likely to push the stock lower in the short term.

02

Market read

BRO's price target reduction and earnings shortfall provide a fresh catalyst for traders, suggesting downside risk.

03

What to watch

Accession acquisition synergies and long‑term margin recovery could offset short‑term miss.

Relevance 7/10Novelty 7/10Timing: after‑hours reaction

Background

Brown & Brown is a U.S. insurance brokerage that recently reported Q3 results and received a revised analyst outlook.

Company-level read

Ticker impact

$BROBearishHigh confidence
Context

Truist lowered its price target on Brown & Brown to $85 and cut 2026‑2027 EPS forecasts after the company reported Q3 earnings that missed estimates.

Expected impact

likely pressure as the market prices in the lower guidance and target.

Evidence & confidence

Analyst target cut and earnings shortfall are fresh, material information that typically drives the stock lower.

Market effects

May weigh on other insurance brokerage stocks as guidance tightening spreads.

Limited to U.S. insurance sector.

Low global impact.

Counterpoint

If the market overreacts, the stock could rebound on the 7% YoY profit growth.

Key entities

  • Brown & Brown

    Insurance brokerage firm (NYSE:BRO).

  • Truist Securities

    Research firm that issued the price‑target cut.

Related articles

$BROHighAI 8/10

Why Brown & Brown Stock Slumped by 5% Today

Brown & Brown (BRO) stock fell 5% after Q3 earnings missed estimates. Revenue rose 7% YoY to $1.73B, below the $1.76B consensus. GAAP net income increased 6% to $240M, while adjusted EPS grew 2% to $1.07, missing the $1.09 estimate. The company cited a challenging rate environment and attributed some growth to its Accession acquisition, but organic revenue grew only 1% YoY to $1.46B.

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.